Daniel Griffith Anderson, Director at Sigilon Therapeutics, Inc. (SGTX), sold 200,000 shares at $10.00 ($2.0M) on 2021-06-02, disclosed to the SEC on 2021-06-04.
Open-market sale of $2.0M SGTX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.